文献速递药疹与重症皮肤不良反应

Stevens-Johnson综合征/中毒性表皮坏死松解症幸存者心血管疾病发病与死亡风险

Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors.
PubMed 文献 · JAMA Dermatol · 2025-01-01

这项基于台湾全国人群的队列研究(1998-2021年)纳入SJS/TEN幸存者,按年龄、性别和Charlson合并症指数匹配非SJS/TEN对照,评估脑血管意外(CVA)和缺血性心脏病(IHD)的发病与死亡风险。结果显示SJS/TEN幸存者CVA发病HR 1.65(95%CI 1.57-1.72)、IHD发病HR 1.58(95%CI 1.51-1.65),心血管死亡风险亦升高,且风险在幸存后1年达峰并持续4至7年。

要点

  • SJS/TEN幸存者CVA发病风险显著升高(HR 1.65,95%CI 1.57-1.72)。
  • SJS/TEN幸存者IHD发病风险显著升高(HR 1.58,95%CI 1.51-1.65)。
  • 心血管死亡风险在幸存后1年达峰并持续4至7年。

核心结论

  • SJS/TEN在急性期后与心血管功能存在持久关联,幸存者心血管发病与死亡风险升高。

研究设计与样本

  • 全国性人群队列研究,使用台湾国家健康研究院数据库链接1998至2021年死亡登记数据库。
  • SJS/TEN幸存者按年龄、性别和Charlson合并症指数与非SJS/TEN参与者匹配。
  • 采用Cox比例风险模型和竞争风险回归模型估计风险比。

主要发现

  • 与非SJS/TEN参与者相比,SJS/TEN患者CVA发病HR为1.65(95%CI 1.57-1.72),sHR为1.40(95%CI 1.33-1.46)。
  • 与非SJS/TEN参与者相比,SJS/TEN患者IHD发病HR为1.58(95%CI 1.51-1.65),sHR为1.32(95%CI 1.26-1.38)。
  • CVA死亡HR为1.69(95%CI 1.46-1.96),IHD死亡HR为1.55(95%CI 1.32-1.82)。
  • 心血管死亡风险在SJS/TEN后1年达峰,并持续4至7年。
  • 年龄较大的幸存者及SJS/TEN诊断时入住ICU的幸存者心血管死亡风险显著更高。

临床怎么用

  • SJS/TEN幸存者急性期后需关注心血管发病与死亡风险,考虑长期随访与风险管理。

局限性

  • 需要利用包含更全面临床数据的数据库或登记系统进一步验证结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) cause diffuse epidermal detachment and necrosis. Patients who survive the initial SJS/TEN episodes are affected by various sequelae. OBJECTIVE: To investigate the risks of cardiovascular morbidity and mortality in SJS/TEN survivors. DESIGN, SETTING, AND PARTICIPANTS: This was a nationwide population-based cohort study using data from Taiwan's National Health Research Institute Database linked to the National Register of Death databases for 1998 to 2021. Survivors of SJS/TEN were identified and matched with non-SJS/TEN participants by age, sex, and Charlson Comorbidity Index. Data analysis was performed from November 2023 to June 2024. EXPOSURE: Cerebrovascular accidents (CVA) or ischemic heart disease (IHD) after SJS/TEN survival. MAIN OUTCOMES AND MEASURES: Cox proportional hazards models were used to estimate the hazard ratios (HRs) of CVA and IHD morbidity and mortality after SJS/TEN survival. RESULTS: The CVA cohort included 10 571 SJS/TEN survivors (mean [SD] age, 56.1 [18.5] years; 5358 females [50.7%] and 5213 males [49.3%]). The IHD cohort included 11 084 SJS/TEN survivors (mean [SD] age, 56.6 [18.6] years; 5561 females [50.2%] and 5523 males [49.8%]). The Cox proportional hazards model and competing risk regression model showed that compared with non-SJS/TEN participants, patients with SJS/TEN had higher risks of cardiovascular morbidity (CVA: HR, 1.65 [95% CI, 1.57-1.72] and subdistribution HR [sHR], 1.40 [95% CI, 1.33-1.46]; IHD: HR, 1.58 [95% CI, 1.51-1.65] and sHR, 1.32 [95% CI, 1.26-1.38]) and death due to cardiovascular disease (CVA: HR, 1.69; 95% CI, 1.46-1.96; IHD: HR, 1.55; 95% CI, 1.32-1.82). The increased cardiovascular mortality risks peaked at 1 year after SJS/TEN and persisted for 4 to 7 years. Older survivors and survivors admitted to an intensive care unit at SJS/TEN diagnosis had significantly higher cardiovascular mortality risk. CONCLUSIONS AND RELEVANCE: In this cohort study, SJS/TEN had a lasting association with cardiovascular function after the acute phase. This suggests a need to mitigate the elevated cardiovascular morbidity and mortality risks among survivors. Further research using databases or registries with more comprehensive clinical data are needed to validate these results.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Chiu HY, Chiu YM. Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors. JAMA Dermatol. 2025. PMID: 39969876. doi:10.1001/jamadermatol.2024.5881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。